Diagnosis and management of inflammatory bowel disease
- PMID: 38934234
- DOI: 10.1111/jebm.12626
Diagnosis and management of inflammatory bowel disease
Abstract
Inflammatory bowel disease (IBD) is a chronic and relapsing immune-mediated disease of the gastrointestinal tract with a gradually increasing global incidence and prevalence. A prolonged course of IBD leads to a decline in patient quality of life and the creation of a substantial economic burden on society. Owing to the lack of specific diagnostic markers, the diagnosis of IBD still needs a gold standard based on a combination of clinical manifestations, imaging, laboratory, and endoscopic results. Accordingly, the current goals of IBD treatment are to alleviate clinical symptoms and reduce recurrence rates. Therefore, it is imperative to develop a standard set of procedures to diagnose and treat IBD. In this review, we summarize prominent and emerging studies, outline classical and contemporary approaches to diagnosing and managing IBD, and integrate multiple guidelines. Furthermore, we propose the possibility of establishing an early and comprehensive diagnostic workflow and personalized management strategy in the future. We aim to enhance the quality and standardization of diagnostic and treatment procedures for IBD.
Keywords: combined diagnostic panels; inflammatory bowel disease; integrating multiple guidelines; management strategies.
© 2024 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.
References
REFERENCES
-
- Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies. Lancet. 2017;390(10114):2769‐2778.
-
- Larsen L, Karachalia Sandri A, Fallingborg J, et al. Has the incidence of inflammatory bowel disease peaked? Evidence from the population‐based NorDIBD cohort 1978–2020. Am J Gastroenterol. 2023;118(3):501‐510.
-
- Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. United European Gastroenterol J. 2022;10(10):1047‐1053.
-
- Chachu KA, Osterman MT. How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD. Inflamm Bowel Dis. 2016;22(5):1262‐1274.
-
- Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(suppl 3):s1‐s106..
Publication types
MeSH terms
Grants and funding
- 2021YFH0189/Sichuan International Science and Technology Innovation Cooperation/Hong Kong/Macao/Taiwan Science and Technology Innovation Cooperation Project
- 2022NSFSC1363/Sichuan International Science Foundation Project
- 2023YFS0279/Sichuan Science and Technology Program
- 2023YFS0287/Sichuan Science and Technology Program
- 2021HXFH065/Project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University
LinkOut - more resources
Full Text Sources
